18F-Floretyrosine Expanded Access Program

NCT06743100 · clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Telix Pharmaceuticals (Innovations) Pty Limited